Explore / Peer-reviewed article
Peer-reviewed articleOpen access

A Review of Synthetic Access to Therapeutic Compounds Extracted from <i>Psilocybe</i>.

Serreau RiD, Amirouche AiD, Benyamina A, Berteina-Raboin SiD

Pharmaceuticals (Basel, Switzerland)Dec 28, 2022License: open accessFrance9 citationsDOI: 10.3390/ph16010040

Abstract

Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various <i>Psilocybe</i>-type hallucinogenic mushrooms. It is difficult, however, to obtain and purify sufficient quantities of these compounds from fungi to carry out biological studies, hence the need to develop simple and efficient synthetic routes. We review here the various syntheses used to obtain these molecules, focusing first on the classic historical syntheses, then the use of more recent metallo-catalyzed couplings and finally the known biocatalytic methods for obtaining these molecules. Other access routes are certainly possible and should be the subject of future research given the therapeutic interest of these compounds.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

Clinical researchTryptaminesPsychedelicsPsilocinPsilocybe MushroomsSynthetic Access

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.